Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer
Condition: Head and Neck Cancer Interventions: Radiation: Proton Stereotactic Body Radiation Therapy (SBRT) (5 fractions; 3500-4500 cGy); Radiation: Proton Stereotactic Body Radiation Therapy (SBRT) (3-5 fractions; various dose and fractionation regimens depending on treatment site).; Drug: Nivolumab 3 mg/kg IV q2 weeks; Radia tion: Proton or Photon SBRT (3-5 fractions; various dose and fractionation regimens depending on treatment site). Sponsor: Mayo Clinic Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Head and Neck Cancer | Immunotherapy | Radiation Therapy | Study